Table 6.
CTV coverage with ADC compared to MC in plans stratified according to number of associated predictors based on multivariate analysis for high γ passing rates are absence of range shifter and presence of mediastinal involvement. (Dpres – dose relative to the prescribed dose of 70 Gy(RBE))
| Metric 2Gy (RBE) (%Dpres) |
PB-PB | PB-MC | PB-MC (scaled) |
|---|---|---|---|
| Absence of RS + mediastinal disease, n = 7 | |||
| CTV D99 | |||
| Median | 70.0 (100) | 67.1 (96) | 70.0 (100) |
| Range | 70.0–70.0 | 66.0–67.7 | 70.0–70.0 |
| CTV mean | |||
| Median | 72.0 (103) | 71.2 (101) | 74.5 (106) |
| Range | 71.8–72.4 | 70.4–71.7 | 73.6–74.7 |
| CTV D2 | |||
| Median | 74.0 (106) | 74.5 (106) | 78.1 (112) |
| Range | 73.6–75.2 | 73.7–75.6 | 76.9–78.8 |
| The rest, n = 13 | |||
| CTV D99 | |||
| Median | 70.0 (100) | 65.4 (93) | 70.0 (100) |
| Range | 70.0–70.0 | 63.1–66.5 | 70.0–70.0 |
| CTV mean | |||
| Median | 72.4 (103) | 69.4 (99) | 74.4 (106) |
| Range | 71.2–73.6 | 67.6–71.1 | 71.1–75.6 |
| CTV D2 | |||
| Median | 74.7 (107) | 73.0 (104) | 78.8 (113) |
| Range | 72.4–76.3 | 70.5–75.1 | 75.9–79.8 |